Rapid CommunicationShort Communication
Pharmacogenomics of Gemcitabine Metabolism: Functional Analysis of Genetic Variants in Cytidine Deaminase and Deoxycytidine Kinase
Jessica A. Roseberry Baker, Enaksha R. Wickremsinhe, Claire H. Li, Olukayode A. Oluyedun, Anne H. Dantzig, Stephen D. Hall, Yue-wei Qian, Barbara J. Ring, Steven A. Wrighton and Yingying Guo
Drug Metabolism and Disposition March 2013, 41 (3) 541-545; DOI: https://doi.org/10.1124/dmd.112.048769
Jessica A. Roseberry Baker
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Enaksha R. Wickremsinhe
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Claire H. Li
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Olukayode A. Oluyedun
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Anne H. Dantzig
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Stephen D. Hall
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Yue-wei Qian
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Barbara J. Ring
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Steven A. Wrighton
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Yingying Guo
Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Rapid CommunicationShort Communication
In Vitro Gemcitabine Pharmacogenomics
Jessica A. Roseberry Baker, Enaksha R. Wickremsinhe, Claire H. Li, Olukayode A. Oluyedun, Anne H. Dantzig, Stephen D. Hall, Yue-wei Qian, Barbara J. Ring, Steven A. Wrighton and Yingying Guo
Drug Metabolism and Disposition March 1, 2013, 41 (3) 541-545; DOI: https://doi.org/10.1124/dmd.112.048769
Rapid CommunicationShort Communication
In Vitro Gemcitabine Pharmacogenomics
Jessica A. Roseberry Baker, Enaksha R. Wickremsinhe, Claire H. Li, Olukayode A. Oluyedun, Anne H. Dantzig, Stephen D. Hall, Yue-wei Qian, Barbara J. Ring, Steven A. Wrighton and Yingying Guo
Drug Metabolism and Disposition March 1, 2013, 41 (3) 541-545; DOI: https://doi.org/10.1124/dmd.112.048769
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement